In vitro antimicrobial activity, antibioresistance reversal properties, and toxicity screen of ethanolic extracts of Heracleum mantegazzianum Sommier and Levier (giant hogweed), Centaurea jacea L. (brown knapweed), and Chenopodium album L. (Pigweed): Three invasive plants.

Background: Plants, including invasive ones, can play a significant role in the fight against antibiotic resistance and the search for new antimicrobials. Aims: The present study aimed at assessing the antimicrobial activity, antibioresistance reversal properties, and toxicity of four samples from invasive plants, namely, Heracleum mantegazzianum (leaves and flowers), Chenopodium album (leaves), and Centaurea jacea (flowers). Methods: The extraction of active compounds was done with ethanol (80%, v/v) and the extraction yields were calculated. Antimicrobial activity was studied using the agar-well diffusion method against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538, and Candida albicans ATCC 10231. Minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) were determined using the mircodilution method. The antibioresistance reversal properties were assessed using the checkerboard method and the toxicity of the extracts was studied using the larval form of the Greater Wax Moth (Galleria mellonella). Results: The mass yields were 11.9, 15.0, 18.2, and 21.5, respectively, for C. jacea flower (CJF), H. mantegazzianum flower (HMF), H. mantegazzianum leaf (HML), and C. album leaf (CAL). The highest inhibition diameters (ID) were found with HMF, CAL, CJF, and HML against S. aureus with 26.6, 21.6, 21.0, and 20.0 mm, respectively. Only CJF and HMF were active against E. coli with respective ID of 15.3 and 19.0 mm. Except HMF (ID = 13.6 ± 2.0 mm), no other extract was active against C. albicans. Moreover, HMF exhibited the lowest MIC (0.5 mg/ml) and the lowest MBC (1 and 4 mg/ml) against both S. aureus and E. coli. Regarding the synergy test, an additional effect [0.5 ≤ fractional inhibitory concentration (FIC) ≤ 1] was found in almost all the combinations antibiotics + extracts excepted for HMF + (Kanamycin or Ampicillin) against S. aureus and CJF + Ampicillin against E. coli where we found synergy effect (FIC ≤0.5). The median lethal doses (LD50s) of HMF, HML, CAL, and CJF were 20.2, 0.58, 13.2, and 4.0 mg/ml, respectively. Conclusion: Only the ethanolic extract of HMFs showed noteworthy broad spectrum antimicrobial activity.

Review of the current use and evaluation of cell substrates for producing biologicals in selected countries.

In 2010, the WHO guidance document for the evaluation of cell substrates for producing biologicals was replaced with updated recommendations and in May 2013 an implementation workshop on the new recommendations was held in Beijing, China. As part of this workshop, a survey of the use and evaluation of cell substrates for producing biologicals was undertaken and the information obtained was updated in June 2014. The purpose of survey was to capture the status of national requirements related to cell substrates in various countries with particular emphasis on whether or not the updated WHO recommendations had been, or were to be, incorporated into national requirements. This paper reports the outcome of the survey and is based on information provided by regulators in eleven countries. Since the publication of the updated WHO recommendations, several activities such as the implementation workshop and publications have been undertaken by the WHO. The aim of these activities, including the publication of this article, is to contribute to the implementation of WHO recommendations so as to reduce regulatory gaps between national requirements and globally agreed expectations.